Novozymes A/S
OTC: NVZMY0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Basic Materials
- Industry
- Chemicals - Specialty
- CEO
- Ester Baiget
- Employees
- 10,582
- Headquarters
- Bagsvaerd, Denmark
- IPO year
- 2010
- Market cap
- $27.8B
- Website
- https://www.novozymes.com
Loading NVZMY…
Loading profile data…Frequently asked questions about NVZMY
What does Novozymes A/S (NVZMY) do?
Novozymes A/S is a global biotechnology firm that specializes in the creation and distribution of industrial enzymes, microorganisms, and probiotics. Its operational footprint spans across Europe, the Middle East, Africa, North America, Latin America, and the Asia Pacific region. The company's broad range of products caters to numerous sectors:...
Where does NVZMY trade?
Novozymes A/S (NVZMY) trades on the Other OTC.
What sector is NVZMY in?
Novozymes A/S (NVZMY) operates in the Basic Materials sector, specifically in the Chemicals - Specialty industry.
Who is the CEO of Novozymes A/S?
Ester Baiget is the chief executive officer of Novozymes A/S (NVZMY).
Where is Novozymes A/S headquartered?
Novozymes A/S is headquartered in Denmark.
Does NVZMY pay a dividend?
Yes — Novozymes A/S (NVZMY) paid a trailing twelve-month dividend of USD 0.45 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did NVZMY go public?
Novozymes A/S (NVZMY) completed its initial public offering in 2010.
Is NVZMY an ADR?
Yes — NVZMY is an American Depositary Receipt; its underlying shares trade on a non-US exchange. Novozymes A/S reporting and dividends follow the underlying issuer.